E-Health, M-Health and Telemedicine for the Covid-19 Pandemic

Preview this chapter:

E-Health, M-Health and Telemedicine for the Covid-19 Pandemic, Page 1 of 1

< Previous page | Next page > /docserver/preview/fulltext/9789815050509/chap6-1.gif

COVID-19 is a disease whose pathological agent corresponds to the recent mutation of the coronavirus, called SARS-CoV-2. Since March 2020, when the pandemic was declared, many efforts have been made to contain the spread of the disease. Since then, there has been a global mobilization in favor not only of fighting the disease, but also of providing medical care, monitoring and treatment of other diseases, due to the need for social isolation and consequent physical distance. Digital Health - represented by the resources used to produce and make available reliable information about the health status of patients - has been providing assistance to whoever, where and when necessary, through E-health and telemedicine. In order to understand a little about the telemedicine actions developed during this period, a systematic mapping was carried out. The choice of PubMed was made due to citations, mainly in the areas of biomedicine and health. 400 initial articles were analyzed. This chapter aims to present an overview of the world panorama of E-health, m-Health and telemedicine applications, adhered to Sustainable Development Goal 3 (SDG 3), during COVID-19, based on the results of the mapping.